Herein, we observed decreased glutamine consumption, α‐KG production, and glutamate generation after MRPL35 silencing in NSCLC cells, implying that MRPL35 silencing induced glutamine metabolism inhibition to prevent cancer cells from gaining energy. This evidence concerns the gene MRPL35 and non-small cell lung carcinoma.